A microfluidic array of primary mammalian hepatocytes for use in high-throughput drug screening

Bartholomew J. Kane, Michael J. Zinner, Martin L. Yarmush, Mehmet Toner

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Nearly half a billion dollars in resources are lost each time a drug candidate is withdrawn from the market by the Food and Drug Administration (FDA). The number of late-phase drug developmental failures due to liver toxicity could potentially be reduced through the use of hepatocyte-based systems capable of modelling the response of in vivo liver tissue to toxic insults. Here we report the development of a 64 (8×8) element array of microfluidic wells capable of supporting micropatterned primary rat hepatocytes in co-culture with 3T3-J2 fibroblasts.

Original languageEnglish (US)
Title of host publicationMicro Total Analysis Systems - Proceedings of MicroTAS 2005 Conference
Subtitle of host publication9th International Conference on Miniaturized Systems for Chemistry and Life Sciences
PublisherTransducer Research Foundation
Pages421-423
Number of pages3
ISBN (Print)0974361119, 9780974361116
StatePublished - Jan 1 2005
Event9th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2005 - Boston, MA, United States
Duration: Oct 9 2005Oct 13 2005

Publication series

NameMicro Total Analysis Systems - Proceedings of MicroTAS 2005 Conference: 9th International Conference on Miniaturized Systems for Chemistry and Life Sciences
Volume1

Other

Other9th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2005
Country/TerritoryUnited States
CityBoston, MA
Period10/9/0510/13/05

ASJC Scopus subject areas

  • Chemical Engineering (miscellaneous)
  • Bioengineering

Fingerprint

Dive into the research topics of 'A microfluidic array of primary mammalian hepatocytes for use in high-throughput drug screening'. Together they form a unique fingerprint.

Cite this